Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effectiveness, Safety, and Tolerability of Tapentadol PR Versus Oxycodone/Naloxone PR in Non-opioid Pre-treated Subjects With Uncontrolled Severe Chronic Low Back Pain With a Neuropathic Pain Component.

NCT01838616 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.

NCT NCT01838616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01838616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effectiveness, Safety, and Tolerability of Tapentadol PR Versus Oxycodone/Naloxone PR in Non-opioid Pre-treated Subjects With Uncontrolled Severe Chronic Low Back Pain With a Neuropathic Pain Component.
Lead sponsor
Grünenthal GmbH
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2013
Completion date
January 31, 2014
Enrollment
367 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

back pain, low back pain, neuropathic pain